Clinical Trial Update: Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating PEG-encapsulated islet allografts for type 1 diabetes was terminated, with the update addressing safety and efficacy assessments to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• PEG-Encapsulated Islet Allografts

Snippet

Sponsor: Novocell | Conditions: Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: TERMINATED